Literature DB >> 7810292

Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

D W Dickson1, P Davies, C Bevona, K H Van Hoeven, S M Factor, E Grober, M K Aronson, H A Crystal.   

Abstract

In a neuropathological study of 81 brains of prospectively studied subjects of 80 years of age or older at the time of death, 13 cases (16%), including 4 men and 9 women, had hippocampal sclerosis (HpScl) affecting the vulnerable region of the hippocampus. In demented subjects of 80 years of age or older, the frequency of HpScl was even higher, 26%. Cases with HpScl had significantly fewer hippocampal senile plaques (SP) and neurofibrillary tangles (NFT) and parahippocampal NFT than cases without HpScl, but did not differ significantly in any of the other measured pathological parameters. Enzyme-linked analysis of synaptic protein immunoreactivity in a subset of 33 cases demonstrated significant decreases in the hippocampus, but not in frontal, temporal, parietal or parahippocampal cortices. All but 1 of the cases with HpScl had Blessed information, memory and concentration scores (BIMC) of 8 or more, and all were considered to be demented. In some patients memory disturbance was disproportionate to deficits in other cognitive areas. All but 4 of the cases with HpScl had many non-neuritic, amyloid plaques in the neocortex meeting NIA criteria for Alzheimer's disease (AD); however, given the advanced age of the subjects, amyloid plaques were considered to represent age-related cerebral amyloid deposition ("pathological aging") in most cases. Only 3 cases had both many SP and NFT in multiple cortical regions consistent with AD. Another case had brain stem and cortical Lewy bodies consistent with diffuse Lewy body disease (DLBD). A few ballooned neurons were present in the limbic cortices in 3 cases, including one case of dementia with argyrophilic grains (DAG) in limbic and orbital frontal and temporal cortices. The 8 cases without AD, DLBD or DAG included 4 cases in which no other obvious cause of dementia was detected and 4 cases in which HpScl was accompanied by either multiple cerebral infarcts or leukoencephalopathy, or both, that could have contributed to dementia. Patients with HpScl had risk factors, clinical signs and post-mortem pathological findings of cardiovascular disease, but due to the high prevalence of these conditions in very old humans, no significant correlation with HpScl was detected. This study demonstrates that HpScl is a common post-mortem finding in demented, but not normal, elderly subjects. It may contribute to. or be a marker for, the increased risk of dementia in subjects with documented cardiovascular disease or a history of myocardial infarction.

Entities:  

Mesh:

Year:  1994        PMID: 7810292     DOI: 10.1007/bf00293396

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  41 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

3.  A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus.

Authors:  R M Zweig; K M Schegg; J H Peacock; D Melarkey
Journal:  Neurology       Date:  1989-02       Impact factor: 9.910

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  Regional synaptic pathology in Alzheimer's disease.

Authors:  W G Honer; D W Dickson; J Gleeson; P Davies
Journal:  Neurobiol Aging       Date:  1992 May-Jun       Impact factor: 4.673

6.  Primary degenerative dementia without Alzheimer pathology.

Authors:  A W Clark; C L White; H J Manz; I M Parhad; B Curry; P J Whitehouse; J Lehmann; J T Coyle
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

7.  Amyloid angiopathy in diffuse Lewy body disease.

Authors:  E Wu; R B Lipton; D W Dickson
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

8.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

9.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

View more
  109 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

Review 2.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

Review 3.  Update on Hippocampal Sclerosis.

Authors:  Juliana R Dutra; Etty P Cortés; Jean Paul G Vonsattel
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

4.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

5.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Ex vivo T2 relaxation: associations with age-related neuropathology and cognition.

Authors:  Robert J Dawe; David A Bennett; Julie A Schneider; Sue E Leurgans; Aikaterini Kotrotsou; Patricia A Boyle; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2014-02-06       Impact factor: 4.673

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 8.  The episodic memory system: neurocircuitry and disorders.

Authors:  Bradford C Dickerson; Howard Eichenbaum
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Contribution of vascular pathology to the clinical expression of dementia.

Authors:  Dorothea Strozyk; Dennis W Dickson; Richard B Lipton; Mindy Katz; Carol A Derby; Sunhee Lee; Cuiling Wang; Joe Verghese
Journal:  Neurobiol Aging       Date:  2008-11-08       Impact factor: 4.673

Review 10.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.